{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Proposed Rule\" and posted_year = 2006 sorted by posted_date descending", "rows": [["FDA-1977-N-0013-0001", "FDA", "FDA-1977-N-0013", "Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-12-19T05:00:00Z", 2006, 12, "2006-12-19T05:00:00Z", "2007-06-20T03:59:59Z", "2019-03-23T23:59:29Z", "E6-21855", 0, 0, "09000064805d7f3f"], ["FDA-2006-N-0237-0001", "FDA", "FDA-2006-N-0237", "Notice of Proposed Rulemaking re Charging for Investigational Drugs", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-12-14T05:00:00Z", 2006, 12, "2006-12-14T05:00:00Z", "2007-03-21T03:59:59Z", "2016-02-12T22:00:43Z", null, 0, 0, "0900006480456b5d"], ["FDA-2006-N-0238-0001", "FDA", "FDA-2006-N-0238", "Expanded Access to Investigational Drugs for Treatment Use", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-12-14T00:00:00Z", 2006, 12, "2006-12-14T05:00:00Z", "2007-03-15T03:59:59Z", "2025-05-21T09:01:14Z", "06-9684", 0, 0, "0900006480456c8f"], ["FDA-1998-N-0009-0001", "FDA", "FDA-1998-N-0009", "Over-the-Counter Human Drugs; Labeling Requirements; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-12-12T05:00:00Z", 2006, 12, "2006-12-11T05:00:00Z", "2007-04-12T03:59:59Z", "2019-10-10T13:24:46Z", null, 0, 0, "0900006480558e9b"], ["FDA-2006-N-0178-0001", "FDA", "FDA-2006-N-0178", "General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "2006-10-31T05:00:00Z", 2006, 10, "2006-10-30T05:00:00Z", "2007-01-30T04:59:59Z", "2008-07-07T18:20:13Z", null, 0, 0, "0900006480450b90"], ["FDA-2005-N-0464-0008", "FDA", "FDA-2005-N-0464", "Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Public Meeting; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2006-10-31T05:00:00Z", 2006, 10, "2006-10-30T05:00:00Z", "2007-01-27T04:59:59Z", "2016-12-19T17:17:44Z", null, 0, 0, "0900006480450c15"], ["FDA-1978-N-0023-0005", "FDA", "FDA-1978-N-0023", "Skin Bleaching Drug Products For Over-the-Counter Human Use; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-29T04:00:00Z", 2006, 8, "2006-08-28T04:00:00Z", "2006-12-28T04:59:59Z", "2019-09-26T13:15:35Z", "E6-14263", 0, 0, "090000648055f1de"], ["FDA-2005-N-0464-0002", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 201-300)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:33:55Z", null, 0, 0, "0900006480450bee"], ["FDA-2005-N-0464-0001", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 301-319)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:32:51Z", null, 0, 0, "0900006480450bce"], ["FDA-2005-N-0464-0003", "FDA", "FDA-2005-N-0464", "Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 1-100)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2017-08-15T14:35:39Z", null, 0, 0, "0900006480450bf2"], ["FDA-2005-N-0464-0004", "FDA", "FDA-2005-N-0464", "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 101-200)", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-23T04:00:00Z", 2006, 8, "2006-08-23T04:00:00Z", "2006-11-28T04:59:59Z", "2016-03-14T19:19:42Z", null, 0, 0, "0900006480450bf3"], ["FDA-2006-N-0239-0001", "FDA", "FDA-2006-N-0239", "Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-08-22T04:00:00Z", 2006, 8, "2006-08-21T04:00:00Z", "2006-11-21T04:59:59Z", "2015-12-15T22:00:50Z", null, 0, 0, "0900006480456ecf"], ["FDA-1995-N-0063-0010", "FDA", "FDA-1995-N-0063", "Current Good Manufacturing Practice, Quality Control Procedures, Quality\r\nFactors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Reopening of the Comment Period", "Proposed Rule", "Reopening of Comment Period", "2006-08-01T04:00:00Z", 2006, 8, "2006-07-28T04:00:00Z", "2006-09-16T03:59:59Z", "2014-07-17T01:05:26Z", null, 0, 0, "090000648056cbef"], ["FDA-2006-N-0171-0001", "FDA", "FDA-2006-N-0171", "Blood Vessels Recovered With Organs and Intended for Use in Organ Transplantation; Companion Document to Direct Final Rule; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-05-18T04:00:00Z", 2006, 5, "2006-05-12T04:00:00Z", "2006-07-27T03:59:59Z", "2025-05-20T19:58:09Z", "06-4370", 0, 0, "0900006480450945"], ["FDA-2005-N-0343-0001", "FDA", "FDA-2005-N-0343", "Notice of Proposed Rule-Making re Medical Gas Containers and Closures; Current Good Manufacturing Practice Requirements", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-04-10T04:00:00Z", 2006, 4, "2006-04-07T04:00:00Z", "2006-07-11T03:59:59Z", "2016-11-19T02:00:53Z", null, 0, 0, "090000648044954b"], ["FDA-2005-N-0345-0001", "FDA", "FDA-2005-N-0345", "Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-02-02T05:00:00Z", 2006, 2, "2006-01-31T05:00:00Z", "2006-05-03T03:59:59Z", "2025-10-16T22:13:32Z", "E6-1225", 0, 0, "0900006480449864"], ["FDA-1998-P-0032-0001", "FDA", "FDA-1998-P-0032", "Listing of Color Additives Exempt From Certification; Food, Drug, and Cosmetic Labeling: Cochineal Extract and Carmine Declaration; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-01-30T05:00:00Z", 2006, 1, "2006-01-30T05:00:00Z", "2006-05-02T03:59:59Z", "2016-03-11T17:00:14Z", null, 0, 0, "09000064805651d4"], ["FDA-2005-N-0170-0001", "FDA", "FDA-2005-N-0170", "Current Good Manufacturing Practice Regulation and Investigational New Drugs; Companion Document to Direct Final Rule; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-01-17T05:00:00Z", 2006, 1, "2006-01-12T05:00:00Z", "2006-04-04T03:59:59Z", "2015-11-19T02:30:48Z", null, 0, 0, "0900006480440c01"]], "truncated": false, "filtered_table_rows_count": 18, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Proposed Rule", "p2": "2006"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006", "results": [{"value": "FDA", "label": "FDA", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Proposed+Rule&posted_year=2006", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006", "results": [{"value": "Proposed Rule", "label": "Proposed Rule", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2006", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006", "results": [{"value": 2006, "label": 2006, "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "docket_id", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=docket_id"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Proposed+Rule&posted_year=2006&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1085.2042110054754, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}